[go: up one dir, main page]

BR9905867A - Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula - Google Patents

Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula

Info

Publication number
BR9905867A
BR9905867A BR9905867-7A BR9905867A BR9905867A BR 9905867 A BR9905867 A BR 9905867A BR 9905867 A BR9905867 A BR 9905867A BR 9905867 A BR9905867 A BR 9905867A
Authority
BR
Brazil
Prior art keywords
human erythropoietin
recombinant human
gene
epo
cell
Prior art date
Application number
BR9905867-7A
Other languages
English (en)
Inventor
Miguel Carcagno
Marcelo Criscuolo
Carlos Melo
Alejandro Vidal
Original Assignee
Bio Sidus S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25590826&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9905867(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ARP980105609 external-priority patent/AR008358A1/es
Priority claimed from ARP990100679 external-priority patent/AR008363A1/es
Application filed by Bio Sidus S A filed Critical Bio Sidus S A
Publication of BR9905867A publication Critical patent/BR9905867A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/505Erythropoietin [EPO]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

<B>LINHAGEM CELULAR PRODUTORA DE ERITROPOETINA HUMANA RECOMBINANTE E A ERITROPOETINA HUMANA RECOMBINANTE PRODUZIDA POR ESTA CéLULA<D>. O gen codificante para eritropoetina humana (EPO) foi obtido a partir de DNA genómico humana. O gen utilizado não inclui fragmentos de regiões flanqueantes 5' e 3' do gen de EPO que não codificam para a proteína. O gen foi clonado em um plasmídeo de expressão para células eucarióticas que tem como únicos elementos de controle da expressão o promotor primário de vírus SV40 e seu sinal de poliadenilação. As células recombinantes resultantes da transfecção com as construções genéticas utilizadas produz inesperadamente mais de 50 mg de EPO recombinante por litro de meio de cultivo por dia.
BR9905867-7A 1998-11-06 1999-07-07 Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula BR9905867A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP980105609 AR008358A1 (es) 1998-11-06 1998-11-06 Celulas huesped que expresan eritropoyetina humana recombinante y un metodo para producir un polipeptido de epo
ARP990100679 AR008363A1 (es) 1999-02-23 1999-02-23 Linea celular productora de eritropoyetina humana recombinante y la eritropoyetina humana recombinante producida por esta celula.

Publications (1)

Publication Number Publication Date
BR9905867A true BR9905867A (pt) 2001-01-23

Family

ID=25590826

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9905867-7A BR9905867A (pt) 1998-11-06 1999-07-07 Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula

Country Status (10)

Country Link
EP (1) EP1124984B1 (pt)
JP (2) JP2002529100A (pt)
AT (1) ATE420199T1 (pt)
AU (1) AU1470400A (pt)
BR (1) BR9905867A (pt)
CA (1) CA2350335C (pt)
CO (1) CO5241323A1 (pt)
DE (1) DE69940267D1 (pt)
ES (1) ES2321048T3 (pt)
WO (1) WO2000028066A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9905868A (pt) 1998-11-06 2001-01-23 Bio Sidus S A Procedimento de cultivo massivo de células de mamìfero para a obtenção de eritropoetina humana, recombinante e a eritropoetina humana recombinante obtida com tal procedimento
BR9917606A (pt) * 1998-11-06 2002-12-31 Bio Sidus S A Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento
US6777205B1 (en) 1998-11-06 2004-08-17 Sterrenbeld Biotechnologie North America, Inc. Host cells expressing recombinant human erythropoietin
UA92913C2 (ru) * 2005-06-20 2010-12-27 Кадила Хелткере Лимитед Экспрессионный вектор и способы продуцирования высоких уровней белков
EP2592147A1 (en) 2007-10-12 2013-05-15 F. Hoffmann-La Roche AG Protein expression from multiple nucleic acids
CA2789696C (en) * 2010-02-25 2017-11-07 Dana-Farber Cancer Institute, Inc. Braf mutations conferring resistance to braf inhibitors
CN103864913A (zh) 2012-12-18 2014-06-18 联亚生技开发股份有限公司 重组蛋白
PE20191360A1 (es) 2017-03-10 2019-10-01 Hoffmann La Roche Metodo para producir anticuerpos multiespecificos

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010002A (en) * 1983-01-19 1991-04-23 Genentech, Inc. Human t-PA production using vectors coding DHFR protein
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS62501010A (ja) * 1984-12-04 1987-04-23 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド エリトロポエチンの生産方法
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US5641663A (en) * 1985-11-06 1997-06-24 Cangene Corporation Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from steptomyces
JPS62171696A (ja) * 1986-01-23 1987-07-28 Sumitomo Chem Co Ltd ヒトエリスロポエチンの製造方法
JPH02485A (ja) * 1987-08-03 1990-01-05 Yuu Honshiyo 新規なヒトインターロイキン4、該因子を発現させるための組換えベクター及びそのベクターにより形質転換された形質転換体
IL95064A0 (en) * 1990-07-12 1991-06-10 Yeda Res & Dev Molecular cloning of tnf binding protein
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
WO1993000807A1 (en) * 1991-07-03 1993-01-21 Cryolife, Inc. Method for stabilization of biomaterials
JPH05194253A (ja) * 1992-01-16 1993-08-03 Kirin Brewery Co Ltd 水溶性ポリペプチドホルモンを含む徐放性微小粒子状製剤及びその製造法
JP3790567B2 (ja) * 1994-09-30 2006-06-28 武田薬品工業株式会社 徐放剤
IL118201A (en) * 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
JPH09238688A (ja) * 1996-03-11 1997-09-16 Takeda Chem Ind Ltd ヒトmcp−1レセプタータンパク質の製造法および用途
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US5851984A (en) * 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
IL129565A0 (en) * 1996-10-25 2000-02-29 Searle & Co Multi-functional chimeric hematopoietic receptor agonists
JPH10273447A (ja) * 1997-01-29 1998-10-13 Takeda Chem Ind Ltd 徐放性マイクロスフィア、その製造法および用途

Also Published As

Publication number Publication date
EP1124984A4 (en) 2005-05-04
DE69940267D1 (de) 2009-02-26
CO5241323A1 (es) 2003-01-31
WO2000028066A1 (en) 2000-05-18
CA2350335A1 (en) 2000-05-18
JP2010213699A (ja) 2010-09-30
AU1470400A (en) 2000-05-29
JP2002529100A (ja) 2002-09-10
ES2321048T3 (es) 2009-06-01
EP1124984A1 (en) 2001-08-22
EP1124984B1 (en) 2009-01-07
CA2350335C (en) 2013-02-26
ATE420199T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
EP0574402B2 (en) Expression of pace in host cells and methods of use thereof
US6316253B1 (en) Expression vectors, transfection systems, and method of use thereof
NZ336200A (en) Activating expression of an amplifying endogenous gene by homologous recombination
WEISS et al. Cis-acting elements are required for selenium regulation of glutathione peroxidase-1 mRNA levels
Chen et al. A new positive/negative selectable marker, puΔtk, for use in embryonic stem cells
Ojaimi et al. An algal nucleus-encoded subunit of mitochondrial ATP synthase rescues a defect in the analogous human mitochondrial-encoded subunit
Larimer et al. Intersubunit location of the active site of ribulose-bisphosphate carboxylase/oxygenase as determined by in vivo hybridization of site-directed mutants.
US20220195416A1 (en) Rna site-directed editing using artificially constructed rna editing enzymes and related uses
ES2259422T3 (es) Optimizacion de celulas para la activacion endogena del gen.
EP0266190A3 (en) Expression of protein c
CA2203569A1 (en) Nucleotide sequence encoding the enzyme i-scei and the uses thereof
DE3880468D1 (de) Rekombinante dns-expressionsvektoren.
BR9905867A (pt) Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
CA2035900A1 (fr) Proteine a activite urate oxydase, gene recombinant codant pour celle-ci, vecteur d&#39;expression, micro-organismes et cellules transformees
FI862674A0 (fi) Cdna.kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-vaextfaktoraktivitet.
EP0293785A3 (en) Cloning and expression of simian transforming growth factor-ss1
Bonin et al. Photinus pyralis luciferase: vectors that contain a modified luc coding sequence allowing convenient transfer into other systems
Matrajt et al. Amino-terminal control of transgenic protein expression levels in Toxoplasma gondii
DK638989D0 (da) Fremgangsmaade til fremstilling af transformerende vaekstfaktor-beta1 samt derved anvendelige, eukaryotiske celler, cellelinier, polypeptider og nucleotidsekvenser
CA2328506A1 (en) Modifying the expression of the fsh beta gene by homologous recombination
US6762038B1 (en) Mutant cell lines and methods for producing enhanced levels of recombinant proteins
AR008363A1 (es) Linea celular productora de eritropoyetina humana recombinante y la eritropoyetina humana recombinante producida por esta celula.
JP2007228814A (ja) 外来タンパク質の発現用遺伝子カセットおよび外来タンパク質の製造方法
Gunaratne et al. An evolutionarily conserved palindrome in the Drosophila Gld promoter directs tissue-specific expression.
ES2255177T5 (es) Fabricación de proteínas mutadas humanas en células humanas por medio de la recombinación homóloga.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37 INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE A MATERIA PLEITEADA NAO E CONSIDERADA PATENTEAVEL, DIANTE DO ART. 18 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.